CTC
TNDM icon

Central Trust Company’s Tandem Diabetes Care TNDM Stock Holding History

Central Trust Company’s Portfolio TNDM Stock Details TNDM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-20
Closed -$373 – 1516
2025
Q2 		$373 Hold
20
– – ﹤0.01% 1408
2025
Q1 		$384 Hold
20
– – ﹤0.01% 1417
2024
Q4 		$721 Hold
20
– – ﹤0.01% 1398
2024
Q3 		$849 Hold
20
– – ﹤0.01% 1329
2024
Q2 		$806 Hold
20
– – ﹤0.01% 1352
2024
Q1 		$709 Hold
20
– – ﹤0.01% 1338
2023
Q4 		$592 Hold
20
– – ﹤0.01% 1348
2023
Q3 		$416 Buy
+20
New +$549 ﹤0.01% 1340

Other funds holding TNDM

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SC
Sessa Capital New York $5.51B AUM 47.23% 1-Year Est. Return
ACH
ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return
GKIM
GW&K Investment Management Boston, Massachusetts $11.3B AUM 31.98% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
HRCM
Hood River Capital Management Palm Beach Gardens, Florida $9.98B AUM 145.42% 1-Year Est. Return
PIM
Paradice Investment Management Denver, Colorado $532M AUM 29.6% 1-Year Est. Return
FGP
Freestone Grove Partners San Francisco, California $14.2B AUM 24.58% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Central Trust Company's TNDM Position: Q3 2025 in Review

Central Trust Company sold out of Tandem Diabetes Care (TNDM) in Q3 2025, closing a stake of 20 shares — an estimated $373 sold.

Central Trust Company first reported a position in TNDM in Q3 2023 and held it in 8 quarters. The position peaked at $849 in Q3 2024. 255 funds tracked by Wall St. Rank hold TNDM as of Q3 2025.

  • Central Trust Company reported no remaining Tandem Diabetes Care position as of Q3 2025 after selling out during the quarter.
  • Central Trust Company sold 20 Tandem Diabetes Care shares in Q3 2025, an estimated $373.
  • Central Trust Company first reported a position in Tandem Diabetes Care in Q3 2023 and held it in 8 quarters.
  • Central Trust Company's Tandem Diabetes Care position peaked at $849 in Q3 2024.
  • 255 funds tracked by Wall St. Rank held Tandem Diabetes Care as of Q3 2025.

Based on Central Trust Company's 13F filing for Q3 2025, filed 6 Nov 2025.